As Europe’s economy shows signs of recovery amid ongoing challenges, fundamentally sound companies like Novo Nordisk A/S (NVO), SAP SE (SAP), and Novartis AG (NVS) could offer strong investment potential as they benefit from broader macroeconomic trends.
The European Central Bank (ECB) recently lowered its deposit facility rate for the second time this year in response to slowing inflation. Inflation in the eurozone dropped to 2.2% in August, edging closer to the ECB’s 2% target. However, the continent’s economic recovery remains tepid, with GDP growth forecast at 0.8% this year and slight improvements expected through 2026.
